Back

Loss of Y is associated with multi-omic changes in immune cells from Alzheimer's disease patients

Jakalski, M.; Rychlicka-Buniowska, E.; Davies, H.; Sarkisyan, D.; Siedlar, M.; Baran, J.; Weglarczyk, K.; Jaszczynski, J.; Rys, J.; Giedraitis, V.; Klich-Raczka, A.; Kilander, L.; Ingelsson, M.; Dumanski, J. P.; Mieczkowski, J.

2023-02-08 genetic and genomic medicine
10.1101/2023.02.07.23285520 medRxiv
Show abstract

Alzheimers disease (AD) is a common and increasing societal problem due to the extending human lifespan. In males, loss of Y (LOY) in leukocytes is more prevalent in AD patients. We studied DNA methylation, gene expression and other epigenetic changes in monocytes and granulocytes with and without LOY from male AD patients and controls. New candidate genes were identified and numerous genes already implicated in AD pathogenesis were confirmed. We show that multi-omics of leukocytes can define AD candidate genes and we strengthen the role of LOY in disease development. The LOY-associated differences in DNA methylation levels were predominantly observed in regulatory regions, and supported by expression analysis showing down-regulation of immune genes. The single-cell transcriptomics highlighted that the AD patient-specific immune activation dominates over LOY-specific activation. Our findings agree with the hypothesis that age-related dysfunction of immune cells contribute to AD and that LOY is reflected by higher-level epigenetic changes with an AD-specific pattern.

Matching journals

The top 12 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.